Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Microbot Medical Inc.NASDAQ: MBOT
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables remains negative
Q1 FY2026 net receivables was $105K, compared with $0 a year earlier. Over 3 fiscal years it compounded at +32.8% a year.
Context
- Net receivables amounted to 0.1% of total assets at the end of Q1 FY2026, up 0.1 pp from a year earlier.
- Net receivables increased in 1 of the last 3 fiscal years.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 241K USD
- Year-over-year change
- -19.7%
- 4-year CAGR
- +8.5%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 241K | -19.7% |
| FY2024 | 2024-12-31 | 300K | -79.8% |
| FY2023 | 2023-12-31 | 1.49M | +1343.7% |
| FY2022 | 2022-12-31 | 103K | -40.8% |
| FY2021 | 2021-12-31 | 174K | — |
Net Receivables vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Net receivables amounts to 0.1% of total assets for MBOT, versus a peer median of 1.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $93.97M USD | -47.4% | -3.4% | 44.9% | |
| Mar 2026 | $9.89M USD | -18.6% | +22.4% | 19.2% | |
| Mar 2026 | $3.51M USD | +132.4% | -41.6% | 16.2% | |
| Mar 2026 | CA$372.21K CAD | -69.1% | +286.3% | 2.5% | |
| Mar 2026 | CA$340.58K CAD | -1.8% | -13.9% | 1.1% | |
| Mar 2026 | $105K USD | — | +32.8% | 0.1% | |
| Mar 2026 | $12K USD | -93.1% | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding MBOT) | — | -33.0% | -3.4% | 1.1% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.